Dr. Vincent's Publication List: 1999-present
Choose a different time period: 1986-1998
70. "A re-investigation the electronic spectra of chromium(III) picolinate complexes and high yield synthesis and characterization of Cr2(μ-OH)2(pic)4·5H2O (Hpic = picolinic acid)." Chakov, N. E.; Collins, R. A.; Vincent, J. B. Polyhedron 18, 2891-2897 (1999).
71. "Nutritional supplement chromium(III) tris(picolinate) cleaves DNA." Speetjens, J. K.; Collins, R. A.; Vincent, J. B.; Woski, S. A. Chem. Res. Toxicol. 12, 483-487 (1999).
72. "Low-molecular-weight chromium-binding substance and biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ do not cleave DNA under physiologically-relevant conditions." Speetjens, J. K.; Parand, A.; Crowder, M. W.; Vincent, J. B.; Woski, S. A. Polyhedron 18, 2617-2624 (1999).
73. "The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics." Sun, Y.; Mallya, K.; Ramirez, J.; Vincent, J. B. J. Biol. Inorg. Chem. 4, 838-845 (1999).
74. "Piltdown man: combining the instruction of scientific ethics and qualitative analysis." Vincent, J. B. J. Chem. Ed. 76, 1501-1502 (1999).
75. "Propagation of errors in freshman chemistry textbooks: a case study using the magnetic moment of a spinning electron." Vincent, J. B. J. Chem. Ed. 76, 1460-1461 (1999).
76. "Mechanisms of chromium action: low-molecular-weight chromium-binding substance." Vincent, J. B. J. Am. Coll. Nutr. 18, 6-12 (1999).
77. "Method for isolation of bovine low-molecular weight Cr-binding substance and method of use of the same," Vincent, J. B.; Davis, C. M., US Patent 5,872,102, 1999.
78. "The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr." Sun, Y.; Ramirez, J.; Woski, S. A.; Vincent, J. B. J. Biol. Inorg. Chem. 5, 129-136 (2000).
79. "Method of decreasing plasma cholesterol and triglycerides with a chromium-containing complex," Vincent, J. B., US Patent 6,149,948, 2000.
80. "The biochemistry of chromium." Vincent, J. B. J. Nutr. 130, 715-718 (2000).
81. "Elucidating a Biological Role for Chromium at a Molecular Level." Vincent, J. B. Acc. Chem. Res. 33, 503-510 (2000).
82. "The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin." Clodfelder, B. J.; Emamaullee, J.; Hepburn, D. D. D.; Chakov, N. E.; Nettles, H. S.; Vincent, J. B. J. Biol. Inorg. Chem. 6, 608-617 (2001).
83. "Enhancement of post-receptor insulin signaling by trivalent chromium in hepatoma cells is associated with differential inhibition of specific protein-tyrosine phosphatases." Goldstein, B. J.; Zhu, L.; Hager, R.; Zilbering, A.; Sun, Y.; Vincent, J. B. J. Trace Elements Exp. Med. 14, 393-404 (2001).
84. "The stability of the biomimetic cation triaqua-μ-oxohexapropionatotrichromium(III) in vivo in rats." Shute, A. A.; Chakov, N. E.; Vincent, J. B. Polyhedron 20, 2241-2252 (2001).
85. "The bioinorganic chemistry of chromium(III)." Vincent, J. B. Polyhedron 20, 1-26 (2001).
86. "Use of triaqua-μ3-oxohexakis-mu-propionatotrichromium (1+), [Cr3O(O2CCH2CH3)6(H2O)3]+, as a nutritional supplement or in treatment of medical conditions," Vincent, J. B.; Davis, C. M., US Patent 6,197,816, 2001.
87. "In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement." Hepburn, D. D. D.; Vincent, J. B. Chem. Res. Toxicol. 15, 93-100 (2002).
88. "Spectroscopic studies of the dodecanuclear chromium complex Cr12O9(OH)3(pivalate)15: confirmation of the presence of twelve Cr(III) centers and the crystal structure of Cr12O9(OH)3(pivalate)15·2PrOH·9H2O." Royer, A. C.; Rogers, R. D.; Arrington, D. L.; Street, S. C.; Vincent, J. B. Polyhedron 21, 155-165 (2002).
89. "The fate of the biomimetic cation triaqua-μ-oxohexapropionatotrichromium(III) in rats." Shute, A. A.; Vincent, J. B. J. Inorg. Biochem. 89, 272-278 (2002).
90. "The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats." Sun, Y.; Clodfelder, B. J.; Shute, A. A.; Irvin, T.; Vincent, J. B. J. Biol. Inorg. Chem. 7, 852-862 (2002).
91. "The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo." Hepburn, D. D. D.; Marcel Burney, J.; Woski, S. A.; Vincent, J. B. Polyhedron 22, 455-463 (2003).
92. "Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream." Hepburn, D. D. D.; Vincent, J. B. J. Inorg. Biochem. 94, 86-93 (2003).
93. "Nutritional supplement chromium picolinate causes sterility and lethal mutations in drosophila melanogaster." Hepburn, D. D. D.; Xiao, J.; Bindom, S.; Vincent, J. B.; O'Donnell, J. Proc. Nat. Acad. Sci. USA 100, 3766-3771 (2003).
94. "Characterization of Chromodulin by X-ray Absorption and Electron Paramagnetic Resonance Spectroscopies and Magnetic Susceptibility Measurements." Jacquamet, L.; Sun, Y.; Hatfield, J.; Gu, W.; Cramer, S. P.; Crowder, M. W.; Lorigan, G. A.; Vincent, J. B.; Latour, J.-M. J. Am. Chem. Soc. 125, 774-780 (2003).
95. "Chromium(III) complexes." Vincent, J. B. Drugs Fut. 28, 1079-1086 (2003).
96. "Recent advances in the biochemistry of chromium(III)." Vincent, J. B. J. Trace Elements Exp. Med. 16, 227-236 (2003).
97. "1H NMR studies of Cr(III)-imidazole complexes: can 1H NMR be used as a probe of Cr-guanine DNA adducts?" Watson, H.; Hatfield, J.; Vincent, J. B. Inorg. Chim. Acta 344, 265-269 (2003).
98. "Absorption of the biomimetic chromium cation triaqua-m3-oxo-m-hexapropionatotrichromium(III) in rats." Clodfelder, B. J.; Chang, C.; Vincent, J. B. Biol. Trace Element Res. 98, 159-169 (2004).
99. "A comparison of the insulin-sensitive transport of chromium in healthy and model diabetic rats." Clodfelder, B. J.; Upchurch, R. G.; Vincent, J. B. J. Inorg. Biochem. 98, 522-533 (2004).
100. "Chromium-containing biomimetic cation triaqua-m3-oxo-m-hexapropionatotrichromium(III) inhibits colorectal tumor formation in rats." Pickering, A.; Chang, C.; Vincent, J. B. J. Inorg. Biochem. 98, 1303-1306 (2004).
101. "Recent developments in the biochemistry of chromium(III)." Vincent, J. B. Biol. Trace Element Res. 99, 1-16 (2004).
102. "Recent advances in the nutritional biochemistry of trivalent chromium." Vincent, J. B. Proc. Nutr. Soc. 63, 41-47 (2004).
103. "Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats." Clodfelder, B. J.; Gullick, B. M.; Lukaski, H. C.; Neggers, Y.; Vincent, J. B. J. Biol. Inorg. Chem. 10, 119-130 (2005).
104. "The time-dependent transport of chromium in adult rats from the bloodstream to the urine." Clodfelder, B. J.; Vincent, J. B. J. Biol. Inorg. Chem. 10, 383-393 (2005).
105. "Cytochrome c: A biochemistry laboratory course." Vincent, J. B.; Woski, S. A. J. Chem. Ed. 82, 1211-1214 (2005).
106. "High-dose chromium(III) supplementation has no effects on body mass and composition while altering plasma hormone and triglycerides concentrations." Bennett, R.; Adams, B.; French, A.; Neggers, Y.; Vincent, J. B. Biol. Trace Element Res. 113, 53-66 (2006).
107. "Low-molecular-weight chromium-binding substance from chicken liver and American alligator liver." Hatfield, M. J.; Gillespie, S.; Chen, Y.; Li, Z.; Cassady, C. J.; Vincent, J. B. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 144B, 423-431 (2006).
108. "Chromium: a case study in how not to perform nutritional research." Stallings, D.; Vincent, J. B. Curr. Topics Nutraceut. Res. 4, 89-112 (2006).
109. "Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster." Stallings, D. M.; Hepburn, D. D. D.; Hannah, M.; Vincent, J. B.; O'Donnell, J. Mut. Res. 610, 101-113 (2006).
This site is maintained by the web site committee of the Chemistry Department at The University of Alabama. Send comments to the .
College of Arts and Sciences | The University of Alabama | Disclaimer
